Patents by Inventor Menghua XIONG

Menghua XIONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230124390
    Abstract: The present disclosure provides a pH-sensitive membranolytic polymer material and a preparation method and application thereof. The pH-sensitive membranolytic polymer material has the structure shown in Formula (I). At normal physiological pH, the polymer material is hydrophobic neutral, and can be self-assembled into PEG coated nanoparticles with weak interaction with cell membrane; when the pH decreases, the polymer material can be protonated to form an amphiphilic structure consisting of hydrophobic domain and cationic domain, which has strong interaction with the cell membrane and strong membranolytic activity, so the polymer material can kill tumor cells or bacteria efficiently and selectively.
    Type: Application
    Filed: December 13, 2022
    Publication date: April 20, 2023
    Applicants: SOUTH CHINA UNIVERSITY OF TECHNOLOGY, SUN YAT-SEN MEMORIAL HOSPITAL, SUN YAT-SEN UNIVERSITY
    Inventors: Menghua XIONG, Yan BAO, Liangqi HUANG, Xiaochuan WANG, Mingdong LIU, Yangbin LIANG, Jun WANG
  • Patent number: 11225507
    Abstract: The disclosure provides a class of pH-sensitive, helix/random conformation switchable antimicrobial polypeptide (HRS-AMP) compositions as a single agent to selectively kill bacteria (e.g., H. pylori) under acidic condition in the stomach with diminished bacterial resistance compared to currently used antibiotics. Methods of treating bacterial infections in the stomach are also provided.
    Type: Grant
    Filed: January 25, 2018
    Date of Patent: January 18, 2022
    Assignee: The Board of Trustees of the University of Illinois
    Inventors: Jianjun Cheng, Lin-Feng Chen, Menghua Xiong, Yan Bao
  • Patent number: 11124605
    Abstract: The invention provides antimicrobial polypeptides (AMPs) with high radial amphiphilicity. Unlike typical AMPs characterized by facial amphiphilicity or biomimetic antimicrobial polymers with randomly distributed charged and hydrophobic groups, these new AMPs are homo-polypeptides with radially amphiphilic structure. They adopt a stable ?-helical conformation with a hydrophobic helical core and a charged exterior shell, formed by flexible hydrophobic side chains with terminal charge group. The radially amphiphilic polypeptides offer several advantages over conventional AMPs with regard to stability against protease and simplicity of design. They also exhibit high antibacterial activity against both Gram-negative and Gram-positive bacteria and low hemolytic activity. The AMPs thus provide a general platform for treating drug-resistant bacterial infections.
    Type: Grant
    Filed: June 27, 2016
    Date of Patent: September 21, 2021
    Assignee: The Board of Trustees of the University of Illinois
    Inventors: Jianjun Cheng, Menghua Xiong, Ziyuan Song
  • Publication number: 20200399319
    Abstract: The disclosure provides a class of pH-sensitive, helix/random conformation switchable antimicrobial polypeptide (HRS-AMP) compositions as a single agent to selectively kill bacteria (e.g., H. pylori) under acidic condition in the stomach with diminished bacterial resistance compared to currently used antibiotics. Methods of treating bacterial infections in the stomach are also provided.
    Type: Application
    Filed: January 25, 2018
    Publication date: December 24, 2020
    Applicant: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
    Inventors: Jianjun Cheng, Lin-Feng Chen, Menghua Xiong, Yan Bao
  • Publication number: 20180179336
    Abstract: The invention provides antimicrobial polypeptides (AMPs) with high radial amphiphilicity. Unlike typical AMPs characterized by facial amphiphilicity or biomimetic antimicrobial polymers with randomly distributed charged and hydrophobic groups, these new AMPs are homo-polypeptides with radially amphiphilic structure. They adopt a stable ?-helical conformation with a hydrophobic helical core and a charged exterior shell, formed by flexible hydrophobic side chains with terminal charge group. The radially amphiphilic polypeptides offer several advantages over conventional AMPs with regard to stability against protease and simplicity of design. They also exhibit high antibacterial activity against both Gram-negative and Gram-positive bacteria and low hemolytic activity. The AMPs thus provide a general platform for treating drug-resistant bacterial infections.
    Type: Application
    Filed: June 27, 2016
    Publication date: June 28, 2018
    Applicant: The Board of Trustees of the University of Illinois
    Inventors: Jianjun CHENG, Menghua XIONG, Ziyuan SONG